1-year in, now undifferentiated adeno... - Advanced Prostate...

Advanced Prostate Cancer

21,447 members26,867 posts

1-year in, now undifferentiated adenocarcinoma, next?

PeakClimber profile image
9 Replies

I've been on Lupron and Apalutamide for one year. Last night my MO informed that despite undetectable PSA there are new hot spots on sacrum, lymph nodes, rib, etc. I live in Boston area and get care at Dana Farber. Proposed care plan is docetaxel and carboplatin. Two questions if friends can help at all:

1. With this rapid and radical change in my status and care plan it seems that a second opinion could be advisable. Do you agree? If so, any recommendations?

2. Have others been down this road? Any advice for this guy who thought he had adjusted to the new reality and now evidently has taken another blow?

THANK YOU, THANK YOU

Written by
PeakClimber profile image
PeakClimber
To view profiles and participate in discussions please or .
Read more about...
9 Replies
Tall_Allen profile image
Tall_Allen

I doubt you'll do much better than DF. They have "tumor boards" so that even doctors there that you have no interaction with review your case and suggest options. You might ask your MO to biopsy one of those new metastases for a pathological analysis and (if there is enough tissue) a genomic analysis. MD Anderson doing a trial of Jevtana+carboplatin followed by a PARP inhibitor. You can talk to your MO about replicating that per protocol since all of those drugs are now FDA approved.

PeakClimber profile image
PeakClimber in reply to Tall_Allen

Thanks TA, one year ago on diagnosis I decided on DF and have appreciated their care (although not the outcomes). Now I'm wrestling with whether a treatment opinion from outside might have any incremental value. I'd expect to continue at DF.

I did have a biopsy which is the source of the undifferentiated pathology report. Samples were also processed against the DF molecular panel, they call the ONCA Panel.

Tall_Allen profile image
Tall_Allen in reply to PeakClimber

Undifferentiated is difficult because it doesn't respond to most therapies. I know that Michael Scweizer at SCCA is running a clinical trial of "double negative" prostate cancer; i.e., where biopsy shows low expression of both AR and neuroendocrine markers. You may want to contact him directly:

clinicaltrials.gov/ct2/show...

SCCA is certainly one of the top prostate cancer oncology centers. I know and like Evan Yu there.

in reply to Tall_Allen

Just saw Dr. Yu this morning. I am a big fan.

timotur profile image
timotur

PC: you may check out the posts from board member tom67inMA, who's developed NEPC and is going through chemo I believe. He's writing a blog with a lot of information about his journey....

tominmotion.blogspot.com/2020/

PeakClimber profile image
PeakClimber in reply to timotur

Thank you timotur I'll check that out.

podsart profile image
podsart

What scan was used-FDG?

PeakClimber profile image
PeakClimber in reply to podsart

I don't know FDG? I had bone scans and CT scans and a biopsy of the growth in the fifth rib between spine and arm pit, I've described the location as behind my right shoulder blade.

podsart profile image
podsart in reply to PeakClimber

Thanks

Good luck

You may also like...

Now off Xtandi trial. Rechallenging with Taxotere next.

MO said PSA is no longer reliable indicator for hubby. We’ve followed the standard of care except...

Raising PSA now 0.20 - Next Move?

two lymph nodes out of 25 extracted. post psa undetectable until 6/20/17 with psa of 0.12. psa...

Side Effects at 1 year

Peace-1 trial Lupron (3 month injection) + 250mg Abiraterone/ 10mg Prednisone + 6 cycles Docetaxel...

Advice for next steps for 82 year old dad

eight years. Upon diagnosis his PSA was 257 and he had a single lymph node found to be involved. He...

25+ Plus years but now on Lupron

I had a undetectable PSA for 12 years. In my 15th year I had Radiation which reduced my PSA...